ARMP R&D to Revenue
Armata Pharmaceuticals, Inc. Common Stock · R&D to Revenue
ARMP R&D to Revenue
Latest reported302.23%period ending
ARMP Quarterly R&D/Revenue (0.00% → 302.23%)
Latest values, visible window
High-resolution chart · PNG
ARMP r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 302.2311% | |
| 774.5247% | |
| 0% | |
| 0% | |
| 294.7902% | |
| 1,105.7026% | |
| 684.2105% | |
| 319.038% | |
| 0% | |
| 829.8137% | |
| 518.8482% | |
| 651.2653% | |
| 842.7551% | |
| 1,206.5327% | |
| 910.4662% | |
| 627.8027% | |
| 479.0228% | |
| 649.5146% | |
| 486.7543% | |
| 449.7202% | |
| 447.3459% | |
| 408.0675% | |
| 988.0952% | |
| 1,411.8056% | |
| 8,541.9355% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 5,450% | |
| -2,181.5789% | |
| 4,035.7143% | |
| 5,137.931% | |
| 3,645.4545% | |
| 5,706.8966% | |
| 1,204.8544% | |
| 1,867.9245% | |
| 949.2188% | |
| 509.0909% | |
| 1,055.8824% | |
| 952.9412% | |
| 1,129.2929% | |
| 1,751.4563% | |
| 605.1613% | |
| 967.3077% | |
| -14,287.5% | |
| -37,433.3333% | |
| 1,144.9045% | |
| 2,913.6364% | |
| 40.8246% | |
| 56.2463% | |
| 104.8986% | |
| 173.6161% | |
| 183.2377% | |
| 185.7845% | |
| 157.9032% | |
| 151.2112% | |
| 158.5755% | |
| 175.1995% | |
| 222.5166% | |
| 99.7754% | |
| 155.2187% | |
| 260.4668% | |
| 151.3169% | |
| 215.9979% | |
| 316.9619% | |
| 328.8646% | |
| 226.95% | |
| 124.2538% | |
| 178.727% | |
| 174.8642% | |
| 320.9848% | |
| 317.694% | |
| 78.9084% | |
| 210.7647% | |
| 80.5462% | |
| 137.7968% | |
| 159.353% | |
| 181.2541% | |
| 168.324% | |
| 184.9942% | |
| 160.6898% | |
| 152.9846% | |
| 168.0158% | |
| 578.7102% | |
| 71.0232% | |
| 258.8705% | |
| 170.9425% | |
| 142.8571% | |
| 257.1429% | |
| 233.3333% | |
| 246.1538% | |
| 64.7887% | |
| 2,900% | |
| 1,300% |